Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 197

1.

Erratum to: The Intensive Care Global Study on Severe Acute Respiratory Infection (IC‑GLOSSARI): a multicenter, multinational, 14-day inception cohort study.

Sakr Y, Ferrer R, Reinhart K, Beale R, Rhodes A, Moreno R, Timsit JF, Brochard L, Thompson BT, Rezende E, Chiche JD; IC-GLOSSARI Investigators; ESICM Trials Group.

Intensive Care Med. 2016 May;42(5):953. No abstract available.

PMID:
27038479
2.

Should ARDS be renamed diffuse alveolar damage?

Thompson BT, Guérin C, Esteban A.

Intensive Care Med. 2016 May;42(5):653-5. doi: 10.1007/s00134-016-4296-5. Epub 2016 Mar 14. No abstract available.

PMID:
26972901
3.

Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries.

Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, Ranieri M, Rubenfeld G, Thompson BT, Wrigge H, Slutsky AS, Pesenti A; LUNG SAFE Investigators; ESICM Trials Group.

JAMA. 2016 Feb 23;315(8):788-800. doi: 10.1001/jama.2016.0291.

PMID:
26903337
4.

The presence of diffuse alveolar damage on open lung biopsy is associated with mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis.

Cardinal-Fernández P, Bajwa EK, Dominguez-Calvo A, Menéndez JM, Papazian L, Thompson BT.

Chest. 2016 Feb 16. pii: S0012-3692(16)01254-X. doi: 10.1016/j.chest.2016.02.635. [Epub ahead of print]

PMID:
26896701
5.

Steroids are part of rescue therapy in ARDS patients with refractory hypoxemia: no.

Thompson BT, Ranieri VM.

Intensive Care Med. 2016 May;42(5):921-3. doi: 10.1007/s00134-016-4255-1. Epub 2016 Feb 16. No abstract available.

PMID:
26883256
6.

The Intensive Care Global Study on Severe Acute Respiratory Infection (IC-GLOSSARI): a multicenter, multinational, 14-day inception cohort study.

Sakr Y, Ferrer R, Reinhart K, Beale R, Rhodes A, Moreno R, Timsit JF, Brochard L, Thompson BT, Rezende E, Chiche JD; IC-GLOSSARI Investigators; ESICM Trials Group.

Intensive Care Med. 2016 May;42(5):817-28. doi: 10.1007/s00134-015-4206-2. Epub 2016 Feb 15. Erratum in: Intensive Care Med. 2016 May;42(5):953.

PMID:
26880091
7.

Non-linear imputation of PaO2/FIO2 from SpO2/FIO2 among patients with Acute Respiratory Distress Syndrome.

Brown SM, Grissom CK, Moss M, Rice TW, Schoenfeld D, Hou P, Thompson BT, Brower RG; NIH/NHLBI PETAL Network.

Chest. 2016 Jan 19. pii: S0012-3692(16)00458-X. doi: 10.1016/j.chest.2016.01.003. [Epub ahead of print]

PMID:
26836924
8.

Impact of Initial Central Venous Pressure on Outcomes of Conservative Versus Liberal Fluid Management in Acute Respiratory Distress Syndrome.

Semler MW, Wheeler AP, Thompson BT, Bernard GR, Wiedemann HP, Rice TW; National Institutes of Health National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network.

Crit Care Med. 2016 Apr;44(4):782-9. doi: 10.1097/CCM.0000000000001555.

PMID:
26741580
9.

Acute respiratory distress syndrome: shifting the emphasis from treatment to prevention.

Gong MN, Thompson BT.

Curr Opin Crit Care. 2016 Feb;22(1):21-37. doi: 10.1097/MCC.0000000000000275.

PMID:
26645554
10.

Volume Delivered During Recruitment Maneuver Predicts Lung Stress in Acute Respiratory Distress Syndrome.

Beitler JR, Majumdar R, Hubmayr RD, Malhotra A, Thompson BT, Owens RL, Loring SH, Talmor D.

Crit Care Med. 2016 Jan;44(1):91-9. doi: 10.1097/CCM.0000000000001355.

PMID:
26474111
11.

Predictors of Circulating Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-Binding Protein-3 in Critical Illness.

Ahasic AM, Tejera P, Wei Y, Su L, Mantzoros CS, Bajwa EK, Thompson BT, Christiani DC.

Crit Care Med. 2015 Dec;43(12):2651-9. doi: 10.1097/CCM.0000000000001314.

PMID:
26427594
12.

Prone positioning and neuromuscular blocking agents are part of standard care in severe ARDS patients: no.

Ferguson ND, Thompson BT.

Intensive Care Med. 2015 Dec;41(12):2198-200. doi: 10.1007/s00134-015-4043-3. Epub 2015 Sep 23. No abstract available.

PMID:
26399891
13.

Effects of inhaled CO administration on acute lung injury in baboons with pneumococcal pneumonia.

Fredenburgh LE, Kraft BD, Hess DR, Harris RS, Wolf MA, Suliman HB, Roggli VL, Davies JD, Winkler T, Stenzler A, Baron RM, Thompson BT, Choi AM, Welty-Wolf KE, Piantadosi CA.

Am J Physiol Lung Cell Mol Physiol. 2015 Oct 15;309(8):L834-46. doi: 10.1152/ajplung.00240.2015. Epub 2015 Aug 28.

PMID:
26320156
14.

Clinical impact of stress dose steroids in patients with septic shock: insights from the PROWESS-Shock trial.

Póvoa P, Salluh JI, Martinez ML, Guillamat-Prats R, Gallup D, Al-Khalidi HR, Thompson BT, Ranieri VM, Artigas A.

Crit Care. 2015 Apr 28;19:193. doi: 10.1186/s13054-015-0921-x.

15.

Estimating dead-space fraction for secondary analyses of acute respiratory distress syndrome clinical trials.

Beitler JR, Thompson BT, Matthay MA, Talmor D, Liu KD, Zhuo H, Hayden D, Spragg RG, Malhotra A.

Crit Care Med. 2015 May;43(5):1026-35. doi: 10.1097/CCM.0000000000000921.

16.

Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome.

Liu KD, Wilson JG, Zhuo H, Caballero L, McMillan ML, Fang X, Cosgrove K, Calfee CS, Lee JW, Kangelaris KN, Gotts JE, Rogers AJ, Levitt JE, Wiener-Kronish JP, Delucchi KL, Leavitt AD, McKenna DH, Thompson BT, Matthay MA.

Ann Intensive Care. 2014 Jul 3;4:22. doi: 10.1186/s13613-014-0022-z. eCollection 2014.

17.

ARDS: lessons learned from the heart.

Cardinal-Fernández P, Esteban A, Thompson BT, Lorente JA.

Chest. 2015 Jan;147(1):7-8. doi: 10.1378/chest.14-0874. No abstract available.

PMID:
25560852
18.

Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.

Wilson JG, Liu KD, Zhuo H, Caballero L, McMillan M, Fang X, Cosgrove K, Vojnik R, Calfee CS, Lee JW, Rogers AJ, Levitt J, Wiener-Kronish J, Bajwa EK, Leavitt A, McKenna D, Thompson BT, Matthay MA.

Lancet Respir Med. 2015 Jan;3(1):24-32. doi: 10.1016/S2213-2600(14)70291-7. Epub 2014 Dec 17.

19.

Preventing ARDS: progress, promise, and pitfalls.

Beitler JR, Schoenfeld DA, Thompson BT.

Chest. 2014 Oct;146(4):1102-13. doi: 10.1378/chest.14-0555.

20.

In septic shock, MAP targets of 80 to 85 mm Hg vs 65 to 70 mm Hg did not differ for 28-day mortality.

Thompson BT.

Ann Intern Med. 2014 Jul 15;161(2):JC7. doi: 10.7326/0003-4819-161-2-201407150-02007. No abstract available.

PMID:
25023273
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk